Practice Point® CME Podcasts: Expert Discussions in Immunology™

Practice Point Communications

Welcome to our podcast where leading experts explore the fascinating world of the immune system and its critical role in health and disease. Each episode dives into the latest research, discoveries, and breakthroughs in immunology, covering topics from autoimmune diseases to immunotherapies. In these podcasts, leading immunologists offer a deep understanding of how the immune system protects us—and how it can sometimes go awry. These episodes provide expert knowledge and real-world applications in this ever-evolving field.

  1. Episode 16 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Patient-Centered Care Podcast - Part 3

    MAR 27

    Episode 16 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Patient-Centered Care Podcast - Part 3

    Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes. These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules. Launch Date: March 27, 2025 Release Date: March 27, 2025 Expiration Date: February 28, 2026 FACULTY Alice Gottlieb, MD, PhD Clinical Professor, Icahn School of Medicine at Mount Sinai Mark Lebwohl, MD Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology Mount Sinai Health System Philip Mease, MD Director, Rheumatology Research, Providence Swedish Medical Clinical Professor, University of Washington School of Medicine This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    28 min
  2. Episode 15 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Early Diagnosis and Screening/Managing Comorbidities Podcast - Part 2

    MAR 27

    Episode 15 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Early Diagnosis and Screening/Managing Comorbidities Podcast - Part 2

    Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes. These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules. Launch Date: March 27, 2025 Release Date: March 27, 2025 Expiration Date: February 28, 2026 FACULTY Alice Gottlieb, MD, PhD Clinical Professor, Icahn School of Medicine at Mount Sinai Mark Lebwohl, MD Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology Mount Sinai Health System Philip Mease, MD Director, Rheumatology Research, Providence Swedish Medical Clinical Professor, University of Washington School of Medicine This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    25 min
  3. Episode 14 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Personalized Treatment Strategies Podcast - Part 1

    MAR 27

    Episode 14 - Conversations in Psoriasis and Psoriatic Arthritis: Evolving Strategies in PsO and PsA: A Clinical Guide for Optimized Patient Care - Personalized Treatment Strategies Podcast - Part 1

    Managing psoriasis (PsO) and psoriatic arthritis (PsA) presents multiple challenges for healthcare professionals, including staying up to date with emerging therapies, recognizing early signs of PsA, managing comorbidities, and implementing multidisciplinary care strategies. Despite advances in biologic and systemic therapies, unmet needs persist in timely diagnosis, patient education, and comprehensive disease management. Busy healthcare professionals often lack the time for in-depth study of the latest research, creating a critical need for concise, accessible educational opportunities. These unmet needs point to the necessity of practical, time-efficient programs that provide actionable insights into new treatment protocols and improve patient outcomes. These podcast episodes are designed to provide healthcare professionals with an in-depth exploration of the most recent advances in the management of psoriasis (PsO) and psoriatic arthritis (PsA). The segments will focus on key challenges in clinical practice, including early diagnosis, personalized treatment strategies, and the integration of patient-reported outcomes. It will also address the management of associated comorbidities and the latest therapeutic developments, including biologics and small molecules. Launch Date: March 27, 2025 Release Date: March 27, 2025 Expiration Date: February 28, 2026 FACULTY Alice Gottlieb, MD, PhD Clinical Professor, Icahn School of Medicine at Mount Sinai Mark Lebwohl, MD Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai Professor & Chair Emeritus of Kimberly & Eric J. Waldman Dept. of Dermatology Mount Sinai Health System Philip Mease, MD Director, Rheumatology Research, Providence Swedish Medical Clinical Professor, University of Washington School of Medicine This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    25 min
  4. Episode 11 - Optimizing Outcomes in Psoriasis: Exploring the Impact of Rapid Diagnosis and Emerging Therapeutic Agents

    JAN 23

    Episode 11 - Optimizing Outcomes in Psoriasis: Exploring the Impact of Rapid Diagnosis and Emerging Therapeutic Agents

    Estimated to impact at least 125 million people worldwide, the burden of living with psoriasis runs more than skin deep. From the physical impact and comorbidities to the emotional toll that may plague everyday life, many patients still struggle with inadequate disease control, often going untreated or undertreated, despite the myriad treatment options available. There is a significant need for new psoriasis treatment options, and this interactive program is designed to provide expert interpretation of new and emerging data on the treatment of psoriasis, with multidisciplinary expert perspectives on how new agents can impact clinical practice. This podcast will discuss how to help clinicians select the most appropriate treatment as well as address the significant health burdens and comorbidities experienced by many patients with psoriasis. Launch Date: August 15, 2024 Release Date: August 15, 2024 Expiration Date: July 31, 2025 FACULTY Bruce Strober, MD, PhD Clinical Professor Yale University and Central Connecticut University This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast. https://www.practicepointcme.com/CMEHome/optimizing-outcomes-in-psoriasis-exploring-the-impact-of-rapid-diagnosis-and-emerging-therapeutic-agents

    15 min
  5. Episode 10 - Patient-Centered Approaches to Long-Term Prophylaxis in HAE - Part 3: Investigational Drugs for HAE Prophylaxis

    JAN 23

    Episode 10 - Patient-Centered Approaches to Long-Term Prophylaxis in HAE - Part 3: Investigational Drugs for HAE Prophylaxis

    Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE. Launch Date: July 26, 2024 Release Date: July 26, 2024 Expiration Date: June 30, 2025 FACULTY Timothy Craig, DO, FAAAAI, FACP, FACAAI, FACOI Tenured Professor of Medicine Pediatrics and Distinguished Educator Pennsylvania State University Marc Riedl, MD, MS Professor of Medicine University of California, San Diego Clinical Director - US HAEA Angioedema Center University of California, San Diego This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1

    18 min
  6. Episode 9 - Patient-Centered Approaches to Long-Term Prophylaxis in HAE - Part 2: HAE Prophylaxis: Treatment and Unmet Needs

    JAN 23

    Episode 9 - Patient-Centered Approaches to Long-Term Prophylaxis in HAE - Part 2: HAE Prophylaxis: Treatment and Unmet Needs

    Hereditary Angioedema (HAE) poses significant challenges for patients and healthcare providers alike, with recurrent attacks impacting quality of life and posing risks of severe complications. While advancements in treatment options have improved acute management, there remains unmet needs in the realm of long-term prophylaxis. In this podcast series, Dr. Timothy Craig and Dr. Marc Riedl will delve into the complexities of HAE management, focusing specifically on emerging solutions for long-term prophylaxis. Through their discussions, they provide insights into the challenges faced by patients with HAE, the limitations of current prophylactic options, and the potential avenues for innovation and improvement in the long-term management of HAE. Launch Date: July 26, 2024 Release Date: July 26, 2024 Expiration Date: June 30, 2025 FACULTY Timothy Craig, DO, FAAAAI, FACP, FACAAI, FACOI Tenured Professor of Medicine Pediatrics and Distinguished Educator Pennsylvania State University Marc Riedl, MD, MS Professor of Medicine University of California, San Diego Clinical Director - US HAEA Angioedema Center University of California, San Diego This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/patient-centered-approaches-to-long-term-prophylaxis-in-hae-1

    27 min

About

Welcome to our podcast where leading experts explore the fascinating world of the immune system and its critical role in health and disease. Each episode dives into the latest research, discoveries, and breakthroughs in immunology, covering topics from autoimmune diseases to immunotherapies. In these podcasts, leading immunologists offer a deep understanding of how the immune system protects us—and how it can sometimes go awry. These episodes provide expert knowledge and real-world applications in this ever-evolving field.